Marc Gerspacher

1.2k total citations
29 papers, 660 citations indexed

About

Marc Gerspacher is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Marc Gerspacher has authored 29 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Genetics. Recurrent topics in Marc Gerspacher's work include Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (12 papers) and Chemical Synthesis and Analysis (6 papers). Marc Gerspacher is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (12 papers) and Chemical Synthesis and Analysis (6 papers). Marc Gerspacher collaborates with scholars based in Switzerland, Australia and United States. Marc Gerspacher's co-authors include Klaus Seuwen, Rochdi Bouhelal, Edgar Jacoby, Henry Rapoport, Gary P. Anderson, Pascal Furet, N. Subramanian, Robert Mah, Hanspeter Pfander and Christine Fritsch and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Marc Gerspacher

29 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Gerspacher Switzerland 14 441 216 182 64 54 29 660
Jennifer L. Olkowski United States 10 362 0.8× 102 0.5× 133 0.7× 74 1.2× 40 0.7× 16 589
Claudia Rosenbaum Germany 16 445 1.0× 160 0.7× 276 1.5× 90 1.4× 34 0.6× 26 836
Graham E. Jones United Kingdom 15 418 0.9× 188 0.9× 221 1.2× 54 0.8× 26 0.5× 21 700
Justin M. Rothfuss United States 15 720 1.6× 157 0.7× 250 1.4× 112 1.8× 60 1.1× 18 973
Michael A. Kjelsberg United States 10 688 1.6× 464 2.1× 103 0.6× 41 0.6× 16 0.3× 13 967
Michel Perez France 14 403 0.9× 105 0.5× 281 1.5× 109 1.7× 19 0.4× 34 759
Stephen C. McKeown United Kingdom 11 418 0.9× 105 0.5× 114 0.6× 36 0.6× 19 0.4× 21 665
Sylvie Y. Blond United States 19 741 1.7× 72 0.3× 192 1.1× 83 1.3× 59 1.1× 29 1.1k
Paul Beswick United Kingdom 20 443 1.0× 89 0.4× 471 2.6× 83 1.3× 51 0.9× 38 1.0k
Aleksandra Baranczak United States 12 525 1.2× 67 0.3× 300 1.6× 142 2.2× 44 0.8× 18 774

Countries citing papers authored by Marc Gerspacher

Since Specialization
Citations

This map shows the geographic impact of Marc Gerspacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Gerspacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Gerspacher more than expected).

Fields of papers citing papers by Marc Gerspacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Gerspacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Gerspacher. The network helps show where Marc Gerspacher may publish in the future.

Co-authorship network of co-authors of Marc Gerspacher

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Gerspacher. A scholar is included among the top collaborators of Marc Gerspacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Gerspacher. Marc Gerspacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerspacher, Marc, Robin A. Fairhurst, Robert Mah, et al.. (2015). Discovery of a novel tricyclic 4H-thiazolo[5′,4′:4,5]pyrano[2,3-c]pyridine-2-amino scaffold and its application in a PI3Kα inhibitor with high PI3K isoform selectivity and potent cellular activity. Bioorganic & Medicinal Chemistry Letters. 25(17). 3582–3584. 20 indexed citations
2.
Fairhurst, Robin A., Patricia Imbach‐Weese, Marc Gerspacher, et al.. (2015). Identification and optimisation of a 4′,5-bisthiazole series of selective phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3569–3574. 17 indexed citations
3.
Fairhurst, Robin A., Marc Gerspacher, Patricia Imbach‐Weese, et al.. (2015). Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3575–3581. 15 indexed citations
4.
Furet, Pascal, Marc Gerspacher, & Carole Pissot‐Soldermann. (2010). Design of two new chemotypes for inhibiting the Janus kinase 2 by scaffold morphing. Bioorganic & Medicinal Chemistry Letters. 20(6). 1858–1860. 6 indexed citations
5.
Pissot‐Soldermann, Carole, Marc Gerspacher, Pascal Furet, et al.. (2010). Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(8). 2609–2613. 33 indexed citations
6.
Gerspacher, Marc, Pascal Furet, Carole Pissot‐Soldermann, et al.. (2010). 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1724–1727. 21 indexed citations
7.
Gerspacher, Marc, Eva Altmann, Thomas Buhl, et al.. (2010). Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists). Bioorganic & Medicinal Chemistry Letters. 20(17). 5161–5164. 9 indexed citations
8.
Jacoby, Edgar, Rochdi Bouhelal, Marc Gerspacher, & Klaus Seuwen. (2006). The 7 TM G‐Protein‐Coupled Receptor Target Family. ChemMedChem. 1(8). 760–782. 275 indexed citations
9.
Jacoby, Edgar, Rochdi Bouhelal, Marc Gerspacher, & Klaus Seuwen. (2006). The 7TM G‐Protein‐Coupled Receptor Target Family. ChemInform. 37(42). 17 indexed citations
10.
Gerspacher, Marc. (2005). Selective and Combined Neurokinin Receptor Antagonists. Progress in medicinal chemistry. 43. 49–103. 8 indexed citations
11.
Rueeger, Heinrich, Marc Gerspacher, Pascal Rigollier, et al.. (2004). Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(10). 2451–2457. 16 indexed citations
12.
13.
Mah, Robert, Marc Gerspacher, Stefan Stutz, et al.. (2002). Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(16). 2065–2068. 8 indexed citations
14.
15.
Gerspacher, Marc, Robert Mah, Gary P. Anderson, et al.. (2000). N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1467–1470. 9 indexed citations
16.
Gerspacher, Marc, et al.. (1998). Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class. Bioorganic & Medicinal Chemistry Letters. 8(8). 965–970. 17 indexed citations
17.
Gerspacher, Marc, et al.. (1998). Neurokinin antagonists as potential therapies for inflammation and rheumatoid arthritis.. PubMed. 1(1). 73–91. 12 indexed citations
18.
Gerspacher, Marc, Gary P. Anderson, N. Subramanian, et al.. (1997). CGP57698: A Structurally Simple, Highly Potent Peptidoleukotriene (PLT) Antagonist of the Quinoline Type. Advances in experimental medicine and biology. 433. 169–172. 2 indexed citations
19.
Lindén, Anders, et al.. (1996). Extent of salmeterol‐mediated reassertion of relaxation in guinea‐pig trachea pretreated with aliphatic side chain structural analogues. British Journal of Pharmacology. 117(6). 1009–1015. 25 indexed citations
20.
Gerspacher, Marc, et al.. (1993). Strategies in the design of peptidoleukotriene antagonists.. PubMed. 6(1-3). 265–73. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer L. Olkowski Breakdown of academic impact, for papers by Claudia Rosenbaum Breakdown of academic impact, for papers by Graham E. Jones Breakdown of academic impact, for papers by Justin M. Rothfuss Breakdown of academic impact, for papers by Michael A. Kjelsberg Breakdown of academic impact, for papers by Michel Perez Breakdown of academic impact, for papers by Stephen C. McKeown Breakdown of academic impact, for papers by Sylvie Y. Blond Breakdown of academic impact, for papers by Paul Beswick Breakdown of academic impact, for papers by Aleksandra Baranczak
Rankless by CCL
2026